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Abstract
Increasing evidence suggests that speciﬁc physiological measures may serve as biomarkers for successful
treatment to alleviate symptoms of pathological anxiety. Studies of autonomic function investigating
parameters such as heart rate (HR), HR variability and blood pressure (BP) indicated that HR variability is
consistently reduced in anxious patients, whereas HR and BP data show inconsistent results. Therefore,
HR and HR variability were measured under various emotionally challenging conditions in a mouse
model of high innate anxiety (high anxiety behaviour; HAB) vs. control normal anxiety-like behaviour
(NAB) mice. Baseline HR, HR variability and activity did not diﬀer between mouse lines. However, after
cued Pavlovian fear conditioning, both elevated tachycardia and increased fear responses were observed
in HAB mice compared to NAB mice upon re-exposure to the conditioning stimulus serving as the
emotional stressor. When retention of conditioned fear was tested in the home cage, HAB mice again
displayed higher fear responses than NAB mice, while the HR responses were similar. Conversely, in both
experimental settings HAB mice consistently exhibited reduced HR variability. Repeated administration
of the anxiolytic NK1 receptor antagonist L-822429 lowered the conditioned fear response and shifted
HR dynamics in HAB mice to a more regular pattern, similar to that in NAB mice. Additional receiver-
operating characteristic (ROC) analysis demonstrated the high speciﬁcity and sensitivity of HR variability
to distinguish between normal and high anxiety trait. These ﬁndings indicate that assessment of auto-
nomic response in addition to freezing might be a useful indicator of the eﬃcacy of novel anxiolytic
treatments.
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Introduction
Psychiatric disorders are a leading cause of disability
worldwide. However, a considerable part of these
disorders are not adequately diagnosed because
classiﬁcation of the diﬀerent pathologies is based on
symptoms speciﬁed in DSM-IV (APA, 2000) that are
often common to various disorders. Therefore, deﬁn-
ing biological or physiological markers would aid
a more precise diagnosis of psychiatric disorders
including anxiety disorders.
The high degree of correlation between the severity
of anxiety and perturbations of the cardiovascular
system has motivated researchers to analyse auto-
nomic parameters in these pathologies (Goodwin et al.
2009; Vogelzangs et al. 2010). Autonomic function can
be studied in humans by means of various parameters
such as heart rate (HR), blood pressure (BP) and body
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ARTICLEtemperature (BT). Whereas those markers have been
widely characterized as potential predictors for de-
veloping diﬀerent cardiovascular disorders and as-
sociated increased risk of death (Casscells et al. 2005;
Harnik, 2005; Pocock et al. 2001), in psychiatric dis-
orders these markers are not considered consistently
reliable predictors (for review see Berntson et al. 1998).
For example, diﬀerent basal HR and BP regulation
has been observed in anxious patients in diﬀerent
laboratories (for review see Berntson et al. 1998).
Therefore, the ﬁeld has moved towards assessing
other autonomic markers such as HR variability
analysis (for review see Cohen & Benjamin, 2006;
Friedman, 2007). This method provides a measure of
the swings of HR over a certain time period and has
become an important assay to assess the autonomic
nervous system regulation. Speciﬁcally, HR variability
reﬂects qualitatively and quantitatively the cardio-
vascular control mediated by the two components of
the autonomic system, the sympathetic and para-
sympathetic (vagal) system (Pieper & Hammill, 1995).
Linear HR variability analysis is generally performed
using time-domain and frequency-spectrum analyses.
Frequency-spectrum analysis has been used for selec-
tive frequency band to determine high- vs. low-
frequency ratios as an index of sympathovagal balance
in humans (Montano et al. 2009). However, this ap-
proach is less validated in mice and hampered by the
fact that the energy contributing to the analysis in
selected frequency bands represents only a small por-
tion of the signal (y20%) that depends on harmonics,
whereas the data stream has been shown to exert
nonlinear properties (Meyer & Stiedl, 2003). Therefore,
we used the root mean square of successive RR inter-
val diﬀerences of the ECG signal, the root mean square
ofsuccessiveRRintervaldiﬀerences(RMSSD)measure
of time-domain analysis, since it appears to be most
stable with regard to drift-like behaviour of non-
stationary data (Meyer & Stiedl, 2003), which is fre-
quently and reliably used in rodents as an index of
short-term variability or vagal activity.
To date, reduction in HR variability is clinically as-
sociated with an increased risk of cardiac death in
patients with anxiety and/or comorbid mood-
disorder patients (Bleil et al. 2008; Lavoie et al. 2004;
Martens et al. 2008). Such patients show evidence of
altered brain activity in regions involved in emotion-
al/autonomic control (Aihara et al. 2007; Mayberg,
1997; Tolkunov et al. 2010). A reduction in HR varia-
bility is also observed in studies involving animal
models of various psychiatric disorders (Cohen et al.
2007; Grippo et al. 2007; Pattij et al. 2002). However,
so far it is unknown whether assessment of HR
variability may be a valid biological marker for pre-
dicting and/or diagnosing the development, course
and outcome of a speciﬁc psychiatric disorder.
According to deﬁnition, biomarkers are biological in-
dicators that objectively describe normal biological or
pathogenic processes, or responses to a therapeutic
intervention. Therefore, we ﬁrst investigated whether
HR and/or HR variability can be used as indicator of
pathological trait anxiety in a validated psychopatho-
logical mouse model of innate high anxiety-related
behaviour termed ‘HAB’ mouse (Kromer et al. 2005)
vs. the corresponding NAB mouse line with normal
anxiety-related behaviour. Supporting the validity
of this model, HAB mice have been shown to display
altered cortico-limbic activation upon challenge
(Muigg et al. 2009), similar to that observed in patients
with anxiety disorders (Mujica-Parodi et al. 2009).
Female HAB and NAB mice, which also show the
pronounced diﬀerence in anxiety-related behaviour
(Kromer et al. 2005) were used in the present study
since investigation of anxiety-related mechanisms in
female subjects is particularly interesting, given the
higher prevalence of anxiety disorders in women than
in men (Bekker & van Mens-Verhulst, 2007; Johnson &
Stewart, 2010).
Radio-telemetry devices allow the recording of
autonomic markers in freely moving animals (Kramer
& Kinter, 2003; Sgoifo et al. 1996; Stiedl & Spiess, 1997;
Stiedl et al. 1999). This technique was used in combi-
nation with fear conditioning to assess the full range of
HR dynamics from baseline to maximal activation
upon conditioned emotional challenge. Fear con-
ditioning was used as challenge for three main
reasons. First, HR responses by radio-telemetry have
been established to be an index of fear in rodents.
Second, radio-telemetric measurements oﬀers the in-
valuable advantage of providing an independent
concomitant measure to behavioural measures under
home-cage conditions devoid of experimenter-based
interference with proper assessment of undisturbed
baseline values before phasic stimulation by the con-
ditioned stimulus (CS). Third, exaggerated fear re-
sponses have been observed in anxious patients
(for review see Shin & Liberzon, 2010) that can be
modelled in rodents using fear conditioning.
In addition, we wanted to evaluate the cardio-
vascular and behavioural response to anxiolytic drug
treatment. Although benzodiazepines (BDZs) are the
most frequently clinically used anxiolytic drugs,
sedation and cognitive impairment are well known
problems limiting the use of conventional BDZs in
anxiety patients (reviewed in Atack, 2003; Stewart,
2005). Indeed, when we tested the eﬀect of diazepam
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nary experiment, it was not possible to distinguish
the anxiolytic from the sedative eﬀects in HAB mice
(R. Landgraf, personal communication). Moreover,
BDZs are known to induce memory impairments both
in rodents and humans (Harris & Westbrook, 1998;
Sanger et al. 1995). Therefore, to avoid pronounced
sedative eﬀects and confounding eﬀects on fear learn-
ing (disrupted learning) and subsequent fear ex-
pression (e.g. immobility/activity), we used the well
characterized neurokinin 1 (NK1) receptor antagonist
L-822429 (Ebner et al. 2004, 2008; Ebner & Singewald,
2007; Singewald et al. 2008). This and other NK1 re-
ceptor antagonists have been shown to exert anxiolytic
eﬀects in animals and humans (reviewed in Czeh et al.
2006; Ebner et al. 2009). We investigated the sensitivity
and speciﬁcity of the RMSSD biomarker. This was
achieved by utilization of receiver-operating charac-
teristic (ROC) analysis. This procedure has been used
to clinically evaluate the quality of biological bio-
markers in the classiﬁcation of patients with and
without disease states.
Material and methods
Animals
Female HAB and NAB mice (age 8–12 wk, weight
25–30 g, bred on a CD-1 background) that were used
in ﬁrst two experiments were bred in the animal
facilities of the Max Plank Institute of Psychiatry in
Munich, as described previously (Kromer et al. 2005;
Landgraf & Wigger, 2002). For the chronic NK1 re-
ceptor antagonist treatment, mice were bred in the
animal facility of the University Innsbruck. All ex-
periments were approved by the local Ethical Com-
mittee for Animal Care and Use (Bundesministerium
fu ¨r Wissenschaft and Verkehr, Kommission fu ¨r
Tierversuchsangelegenheiten, Austria) and were in
compliance with international laws and policies and
European Council Directive 86/609/EEC.
Implantation of radio-telemetry transmitters
Mice were individually housed starting 24 h before the
onset of surgery until the completion of the behav-
ioural experiments. TA10ETAF20 transmitters (Data
Sciences, USA) were implanted in the animals as de-
scribed previously (Stiedl & Spiess, 1997; Stiedl et al.
1999). For anaesthesia a mixture of sodium pentobar-
bital (40 mg/kg i.p.) and ketamine (50 mg/kg i.p.) was
used. Post-operatively, mice were treated with bupre-
norphine (0.2 mg/kg i.p.) for 3 d. Following surgery,
mice were allowed to recover for 3 wk before the onset
of behavioural testing.
Locomotion and ECG data acquisition and analysis
Locomotor activity and ECG were acquired by the use
of a radio-telemetry system (Data Sciences). Data were
collected at 64 Hz (activity counts) and 2000 Hz (ECG)
using the Dataquest A.R.T. 4.1 software (Data
Sciences). The ECG signal was exported as a text ﬁle
using Dataquest Reader (Data Sciences) and imported
into Chart software (Chart 5.0, AD Instruments,
Germany) for ECG data editing. Brieﬂy, recordings
were edited oﬄine for the correction of unrecognized
beats and exclusion of artifacts via the HR variability
module of the Chart software as described previously
(Stiedl et al. 2005). Pairs of successive R waves of the
ECG signal were used to derive instantaneous read-
ings of HR, measured in beats per min (bpm). HR
variability was determined as the RMSSD in milli-
seconds.
Basal circadian measurement (home cage)
Three weeks after surgery, baseline measurements
(n=6/line) were continuously acquired in the home
cage for a 48-h observation period. Radio-tele-
metrically transmitted data for locomotor activity and
HR were averaged in 1-h intervals. To determine the
full cardiovascular range, basal HR variability ex-
pressed in RMSSD was measured between 09:00 and
11:00 hours for the light phase, when basal HR levels
should be the lowest, and between 23:00 and 01:00
hours for the night phase, when basal HR levels
should be highest (Li et al. 1999). Intervals of 30 s were
used to calculate HR variability.
Novel cage exposure
To assess the eﬀects of novelty on autonomic re-
sponses, naive HAB and NAB mice (n=8/line) were
placed in a clean standard Makrolon cage (22r16r
14 cm) without bedding. Recordings of ECG and
locomotor activity were started in the home cage and
lasted for 30 min. The mice were then placed into the
middle of a new cage and ECG recordings continued
for 30 min. Data for HR and HR variability were
averaged in 30-s intervals and divided into pre-
exposure and novelty.
Fear conditioning
Quantiﬁcation of fear and autonomic responses
Behavioural experiments were video-recorded and
freezing behaviour was assessed from the recording.
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except those associated with breathing (Blanchard &
Blanchard, 1969). Freezing data were averaged in
2-min intervals (duration of CS exposure) and divided
into baseline measurement (pre-CS) and fear response
(CS exposure). Data for locomotor activity, HR and HR
variability were averaged in 30-s intervals and divided
into pre-CS and CS exposure in the fear-conditioning
experiments.
Cued fear conditioning with an air stream as unconditioned
stimulus (US)
After basal measurement, the animals used for novel
cage exposure were fear-conditioned via ﬁve CS (light
intensity 600 lx, 2-min duration) each co-terminating
with a US (air stream, intensity 50 dB, 30-s duration;
Salchner et al. 2006) which has been previously used as
US for aversive conditioning (Landers & Sullivan,
1999). The US was delivered via a plastic tube directed
to the nose of the mouse by the experimenter, who
followed the mouse in its movements for the entire
duration of the US. Stimulus-free periods (2 min)
separated and followed the CS/US pairings. Freezing
during conditioning session was evaluated during the
last CS/US pairings. This paradigm was chosen as it
does not interfere with the radio-telemetry assessment
such as electric shock which is classically used as US.
Conditioning took place in a novel 26r30r32 cm
chamber with transparent walls and a metal grid ﬂoor
(Coulbourn Instruments, USA). Fear retention was
tested 24 h following conditioning by exposing mice to
one CS (light intensity, 2 min, 600 lx) in a new context
(empty cage).
Home-cage cued-fear conditioning
This paradigm was chosen as a possibility of avoiding
non-speciﬁc autonomic eﬀect due to context changes.
Furthermore,weusedmildfootshockasUSsinceithas
already been successfully employed to induce cardio-
vascular and fear responses in this speciﬁc setting
(Stiedl et al. 2009).
After a 2-min acclimation period, conditioning took
place in a novel 26r30r32 cm chamber with trans-
parent walls and a metal grid ﬂoor (Coulbourn
Instruments) under bright light condition (300 lx).
HAB and NAB mice (n=8/line) were fear-con-
ditioned via ﬁve CS (2-min duration, intensity 80 dB,
white noise) each co-terminating with an US (2 s,
0.7 mA scrambled footshock). The CS/US pairings
were separated by 2 min without phasic stimulation.
Twenty four hours later, after a 2-min baseline period
without phasic stimulation, mice received a single CS
presentation (2-min duration, intensity 80 dB, white
noise) in the home cage as fear retention test at low
illumination (red light, 5–10 lx). The freezing response
could not be evaluated during the fear retention in
the home-cage settings, since the cage lid prevented its
assessment. However, correlation analysis between
freezing levels and radio-telemetrically transmitted
locomotor activity after light–CS+air–US retention
testing indicated that the telemetrically detected
activity can serve as an indirect measure of the fear
response (Supplementary Fig. S1, available online).
Drug treatment
Auditory fear conditioning in HAB mice (n=8/treat-
ment group) was performed as described above using
white noise as CS and footshock as US. Freezing dur-
ing the conditioning session was evaluated during the
last of ﬁve CS/US pairings. In the fear-retention test
24 h later, a single CS (2-min duration, intensity 80 dB,
white noise) was presented in a new context (empty
cage) under dim red-light illumination (5–10 lx).
The NK1 receptor antagonist L-822429 [(2S,3S)-N-[2-
cyclopropoxy–5-(5-triﬂuoromethyl)-tetrazol-1-yl]
benzyl-2-phenylpiperidin-3-amine-dihydrochloride]
(Singewald et al. 2008) was dissolved and provided to
mice via drinking water at a dose of 30 mg/kg for 30 d
until the end of the fear-conditioning experiment. The
control group received drinking water only. This dose
was chosen according to preliminary experiments
indicating that L-822429 exerted an anxiolytic eﬀect in
HAB mice in the light/dark test (S. B. Sartori et al.
unpublished data).
Statistical analysis
Statistical analysis was performed using Statistica 8.0
(StatSoft, USA). Analyses of variance (ANOVA) of re-
peated measures were performed with the factor line
(HAB or NAB mice) and repeated measure for time
(light or dark phase of circadian cycle). Two-factor
ANOVAs were performed with factor line (see above)
and second factor light or dark for circadian HR
variability, baseline and novelty for novelty exposure
and pre-CS (before CS presentation, baseline) and CS
(during CS presentation, fear response) for fear con-
ditioning. Signiﬁcant eﬀects were further analysed by
Bonferroni post-hoc comparisons. The ROC curves
were estimated by calculating the area under the curve
(AUC) for HR variability in each of the three fear-
conditioning experiments. A Z score was used to
compare the diﬀerences in areas and standard errors
between the ROC curves according to the method
described previously (Hanley & McNeil, 1982). For
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and S3 Student’s t test was used. For Supplementary
Fig. S2, Pearson product-moment correlation co-
eﬃcient R was calculated between freezing and tele-
metric locomotor activity. The threshold for statistical
signiﬁcance was set to p<0.05.
Results
Circadian changes in locomotor activity, HR and HR
variability
In the home cage, circadian rhythmicity was observed
in both HAB and NAB mice as indicated by higher
locomotor activity (F48,480=4.18, p<0.001, Fig. 1a),
higher HR (F48,480=4.74, p<0.001; Fig. 1b) and re-
duced HR variability (F1,104=74.76, p<0.001, Fig. 1c)
during the dark phase. No signiﬁcant linertime eﬀect
was found for HR (F48,480=1.37, p>0.05) or for loco-
motor activity (F48,480=0.82, p>0.05). Moreover, HR
variability (RMSSD) did not diﬀer between the lines
during the light or dark phases (F1,104=0.343, p>0.05).
Novelty exposure
Novelty exposure was used to determine the eﬀects of
an unconditioned challenge on locomotor activity and
autonomic parameters in HAB and NAB mice. There
was no linernovelty interaction for locomotor activity
(F1,60=3.57, p>0.05; Fig. 2a), HR (F1,60=0.21, p>0.05;
Fig. 2b) or HR variability (F1,60=1.25, p>0.05; Fig. 2c).
ANOVA yielded a signiﬁcant novelty eﬀect for loco-
motor activity (F1,60=566.99, p<0.001; Fig. 2a) in-
dicating a signiﬁcant increase in locomotor activity
in both lines during novelty exposure compared to
baseline values. A signiﬁcant novelty eﬀect was also
found for HR (F1,60=692.38, p<0.001, Fig. 2b) and HR
variability (F1,60=168.28, p<0.001; Fig. 2c). While HR
levels were increased by novelty in both lines com-
pared to baseline values, HR variability was reduced.
Freezing, HR and HR variability in conditioned fear
retention tested with air stream as US
Next, we tested whether there was a diﬀerence in the
autonomic/behavioural responses in a cued fear-con-
ditioning experiment using air stream as US. At the
end of the conditioning session, HAB and NAB mice
showed similar levels of freezing and activity levels
(Supplementary Figs S1A and S1B). However, in-
creased HR and reduced HR variability (Sup-
plementary Figs S1B and S1C) was observed in HAB
mice suggesting that the enhanced autonomic re-
sponse observed in HAB mice might be due to the
anxiety trait rather than induced by the challenge
per se.
During the fear retention test, there was a signiﬁ-
cant linerCS interaction for freezing behaviour
(F1,28=111.97, p<0.001; Fig. 3a) Post-hoc tests showed
that the fear response was higher in HAB than in NAB
mice during CS exposure (Fig. 3a). In both lines,
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Fig. 1. High anxiety behaviour (HAB) and normal
anxiety-like behaviour (NAB) mice displayed similar
locomotor activity and heart rate (HR) patterns in the
home cage. Data collected over 48 h of recordings showed
comparable patterns in (a) spontaneous locomotor activity
and (b) HR [expressed as beats per min (bpm)]; changes in
HAB (white symbols) and NAB mice (black symbols) during
the dark and light (indicated by black and white bars,
respectively, below the x axis) phases. (c) HAB and NAB
mice also exhibited similar basal HR variability (root mean
square of successive RR interval diﬀerences; RMSSD) in the
dark and light phases. Data are means¡S.E.M.( n=6/line).
### p<0.001 dark vs. light phase.
Heart rate variability in high anxiety mice 1345freezing was higher during the CS phase than during
pre-CS phase (Fig. 3a). Furthermore, a signiﬁcant
linerCS interaction was found for locomotor activity
(F1,60=5.54, p<0.001; Fig. 3b). Post-hoc test revealed
reduced locomotor activity of HAB mice upon CS ex-
posure compared to NAB mice (Fig. 3b). A signiﬁcant
linerCS interaction was found for HR (F1,60=59.50,
p<0.001; Fig. 3c). Post-hoc tests revealed higher
tachycardic responses in HAB mice than in NAB mice
(Fig. 3c). Indeed, upon CS exposure HAB mice
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Fig. 2. High anxiety behaviour (HAB) and normal
anxiety-like behaviour (NAB) mice displayed similar basal
and stress-induced locomotor activity and heart rate (HR)
patterns upon novel cage exposure. Compared to baseline
values, exposure to a novel environment in both lines caused
an increase in (a) locomotor activity and (b) HR [expressed as
beats per min (bpm)]; whereas (c) HR variability (root mean
square of successive RR interval diﬀerences; RMSSD) was
reduced. Locomotor activity and autonomic responses did
not diﬀer between HAB (%) and NAB mice (&) under
both basal and novelty conditions. Data are means¡S.E.M.
(n=8/line). ### p<0.001 novelty vs. baseline.
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Fig. 3. High anxiety behaviour (HAB) mice showed increased
fear expression, pronounced tachycardia, and reduced
heart rate (HR) variability in retention of cued-conditioned
fear tested using air stream as unconditioned stimulus.
(a) Upon conditioned stimulus (CS) presentation, fear
expression as indicated by the percentage of freezing was
elevated in both lines but signiﬁcantly more in HAB (%) than
in normal anxiety-like behaviour (NAB) (&) mice. (b) Both,
NAB and HAB mice displayed a reduction in locomotor
activity upon CS exposure. The decrease in locomotor activity
was more pronounced in HAB mice than in NAB mice. (c)C S
induced a tachycardic response in both lines with an
exacerbated increase of HR in beats per min (bpm) in HAB
mice. (d) In contrast, CS presentation reduced HR variability
(root mean square of successive RR interval diﬀerences;
RMSSD) in both lines. Data are means¡S.E.M.( n=8/line).
** p<0.01, *** p<0.001 HAB vs. NAB; # p<0.05, ### p<0.001
CS vs. pre-CS values.
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to 820 bpm that are higher than those previously
reported for other mouse lines (Stiedl et al. 1999).
Furthermore, there was a signiﬁcant linerCS inter-
action for HR variability (F1,60=4.78, p<0.05; Fig. 3d).
Post-hoc tests yielded a reduced HR variability
(RMSSD) in HAB mice compared to NAB mice
(Fig. 3d). Finally, Pearson coeﬃcient demonstrated a
highly signiﬁcant negative correlation (Supplemen-
tary Fig. S2) between freezing responses and loco-
motor activity during the retention test indicating that
telemetrically determined locomotor activity can also
serve as an index of fear response.
HR and HR variability in auditory fear retention
in the home cage
Next, we investigated HR and HR variability re-
sponses to a fear retention test performed in the home
cage. Locomotion, as indicated from the previous cor-
relation analysis, was taken as an indirect measure of
fear response because the lid of the cage prevented
direct visual assessment of freezing. There was a sig-
niﬁcant linerCS interaction for locomotor activity
(F1,60=8.31, p<0.01; Fig. 4a). Post-hoc comparison in-
dicated reduced locomotor activity upon CS presen-
tation compared to baseline conditions. HAB mice
displayed lower activity than NAB mice upon CS ex-
posure (Fig. 4a). There was no linerCS interaction for
HR (F1,60=0.24, p>0.05; Fig. 4b). A main signiﬁcant
CS eﬀect was found indicating increased HR levels
in both lines during CS presentation (F1,60=834.58,
p<0.001; Fig. 4b) compared to baseline values. There
was a signiﬁcant CS phaserline interaction for HR
variability (RMSSD) (F1,60=5.20, p<0.05; Fig. 4c).
Compared to baseline values, post-hoc comparison
showed reduced HR variability (RMSSD) in both lines
during CS presentation. HR variability (RMSSD)
was lower in HAB mice than in NAB mice during CS
exposure.
Eﬀects of the NK1 receptor antagonist L-822429
on conditioned fear retention
Finally, we tested the eﬀects of chronic NK1 receptor
antagonist treatment on altered autonomic responses
in HAB mice and investigated in particular whether
HR variability is sensitive to behaviourally successful
anxiolytic treatment. This was studied by means of a
classical fear-conditioning paradigm with footshock/
sound as the CS/US pairing. During fear conditioning
both mouse lines expressed similar levels of fear
arguing against an inﬂuence of possible analgesic
actions of the NK1 receptor antagonist in this exper-
iment (Supplementary Fig. S3).
A signiﬁcant CSrtreatment interaction was
observed for the freezing response (F1,24=29.47,
p<0.001; Fig. 5a). Post-hoc comparison showed lower
freezing during CS exposure in drug-treated com-
pared to untreated HAB mice. Furthermore, no
signiﬁcant CSrtreatment interaction for locomotor
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Fig. 4. High anxiety behaviour (HAB) mice exhibited reduced
locomotor activity and heart rate (HR) variability to
conditioned auditory fear in the home cage. (a) Presentation
of conditioned stimulus (CS) induced a signiﬁcant reduction
in locomotor activity in HAB (%) and normal anxiety-like
behaviour (NAB) (&) mice. The reduction in activity levels
was more pronounced in HAB mice compared to NAB mice.
(b) The CS presentation induced an increase in HR rate in
beats per min (bpm) along with a decline in (c) HR variability
(root mean square of successive RR interval diﬀerences;
RMSSD) in both lines. However, signiﬁcantly lower HR
variability (RMSSD) was detected in HAB mice than in NAB
mice. Data are means¡S.E.M.( n=8/line). *** p<0.001 HAB
vs. NAB; ## p<0.01, ### p<0.001 CS vs. pre-CS values.
Heart rate variability in high anxiety mice 1347activity was observed (F1,32=1.32, p>0.05; Fig. 5b).
However, a main treatment eﬀect was found (F1,52=
6.96, p<0.05; Fig. 5b) indicating that NK1 receptor
antagonist-treated HAB mice displayed higher loco-
motor activity than HAB control mice. Furthermore,
Student’s t test revealed similar locomotor pre-CS ac-
tivity between drug-treated compared to untreated
HAB mice (t14=x1.06, p>0.05).
No signiﬁcant CSrtreatment interaction was ob-
served for HR (F1,52=0.45, p>0.05; Fig. 5c). However,
a main CS eﬀect (F1,52=668.79, p<0.001) but not a
treatment eﬀect (F1,52=2.60, p>0.05) was observed in-
dicating similar elevation in HR during CS exposure in
both groups.
There was a signiﬁcant CSrtreatment interaction
forHRvariability(F1,52=3.85,p<0.05;Fig.5d).Post-hoc
comparison indicated enhanced HR variability in NK1
receptor antagonist-treated compared to untreated
HAB mice during CS presentation. HR variability did
not diﬀer under baseline conditions (pre-CS values)
between treated and control HAB mice.
HR/HR variability curve analysis
The relationship between HR (RR interval) and its
variability (HR variability, quantiﬁed by the RMSSD
measure) was compared in HAB and NAB mice
(Fig. 6). The linear relationship between HR vs.
RMSSD was determined in HAB and NAB mice along
the whole dynamical range of HR encountered during
baseline measurements and after HR adjustments in
response to CS. The results indicated that HR varia-
bility is inversely related to absolute HR. Signiﬁcant
correlations between HR and HR variability were de-
termined in NAB mice (F1,406=416.86, p<0.001) and
HAB mice without treatment (F1,228=56.44, p<0.001)
and after chronic NK1 receptor antagonist treatment
(F1,91=8.75, p<0.01). The linear relationship ap-
proached minimum RMSSD values at maximum HR
(generally y800 bpm; RR interval y75 ms). However,
maximum HR values approached 850 bpm (RR inter-
val y70 ms) in HAB mice. Chronic treatment with
the NK1 antagonist L-822429 reduced the slope of the
RR/RMMSD relationship below the slope observed
in NAB mice, i.e. resulted in a higher regularity of HR
dynamics, and appeared to have limited maximum
HR to values below 800 bpm.
Sensitivity, speciﬁcity and ROC curves
Analysis of the AUC assessed the diagnostic accuracy
distinguishing between normal and high anxiety trait
in the three sets of fear-conditioning experiments
(Fig. 7). The AUCs for HR variability in the three sets
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Fig. 5. Chronic treatment with the NK1 receptor antagonist
L-822429 caused a reduction in fear expression and a
normalization of heart rate (HR) variability in high anxiety
behaviour (HAB) mice. (a) The conditioned stimulus (CS)
presentation produced signiﬁcant increased fear expression
in untreated (%) but not drug-treated (&) HAB mice. (b) Both
control and L-822429-treated HAB mice displayed a
reduction in locomotor activity upon CS exposure, which was
less pronounced in the treatment group. (c) CS presentation
elicited elevated HR [beats per min (bpm)] in both groups.
(d) Compared to HAB controls, L-822429-treated HAB mice
displayed an increased HR variability (root mean square of
successive RR interval diﬀerences; RMSSD) upon CS
exposure. Data are means¡S.E.M.( n=7/group). * p<0.05,
*** p<0.001 L-822429-treated vs. untreated HAB groups;
## p<0.01, ### p<0.001 CS vs. pre-CS values.
1348 S. Gaburro et al.of fear-conditioning experiments were 1.00, 1.00 and
0.964¡0.033. The Z scores did not reveal any statistical
diﬀerence between the AUC of the three experiments.
The optimal cut-oﬀ of HR variability levels deter-
mined from the ROC curves were as follows: 0.587 ms
for the ﬁrst conditioned fear experiment, 0.723 ms for
the home-cage fear conditioning and 0.633 ms for the
experiment with NK1 receptor antagonist treatment.
The sensitivity and speciﬁcity for the cut-oﬀ values of
>0.587 ms and >0.723 ms demonstrated 100% speci-
ﬁcity and sensitivity, whereas the cut-oﬀ value of
>0.633 ms demonstrated a sensitivity and speciﬁcity
of 92.9%.
Discussion
The main ﬁnding of the present study is that HR
variability is reduced in HAB mice compared to NAB
mice as consistently revealed in fear retention tests
using diﬀerent (auditory and visual) fear-conditioning
paradigms. This altered autonomic state was behav-
iourally associated with an enhanced fear response.
NK1 receptor antagonist treatment reduced the fear
response and altered autonomic response (i.e. in-
creased HR variability at high HR but decreased HR
7
(a)
(b)
6
5
4
3
R
M
S
S
D
 
(
m
s
)
2
1
0
2
1.5
1
0.5
R
M
S
S
D
 
(
m
s
)
0
70
70 75 80 85 90
80 90 100
RR interval (ms)
110 120 130 140
RR interval (ms)
HAB
NAB
HAB +
NK1-A
HAB
NAB
HAB +
NK1-A
NAB mice: y = –1.61 + 0.032x; R
2= 0.198
HAB mice: y = –3.212 + 0.049x; R
2= 0.507
HAB mice + NK1-A: y = –0.815 + 0.022x; R2= 0.088
NAB mice
HAB mice
HAB mice
+ L-822429
Fig. 6. RR vs. RMSSD correlation analysis of high anxiety
behaviour (HAB) and normal anxiety-like behaviour (NAB)
mice across the diﬀerent fear-conditioning experiments.
(a) The correlation analysis shows that RR intervals are
negatively correlated with root mean square of successive RR
interval diﬀerence (RMSSD) values. Moreover, the lines show
a diﬀerent steepness of slope of the linear HR/RMSSD
correlation function that is further shifted to reduced increase
of heart rate (HR) variability with decreasing HR (increasing
RR interval) upon treatment with the NK1 antagonist
L-822429. (b) The zoom depicts the range of maximum
HR/minimum HR variability in NAB mice and untreated
vs. L-822429-treated HAB mice. The dashed line in panel
(a) denotes the RR/RMSSD correlation in C57BL/6N mice
for comparison (data as reported by Tovote et al. 2004).
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Fig. 7. ROC curves of heart rate (HR) variability during the
diﬀerent fear-conditioning paradigms for discriminating
mice with high anxiety behaviour (HAB) from those with
normal anxiety-like behaviour (NAB). –#–, HR variability
analysis (HRV1) during the ﬁrst conditioned fear experiment;
––!––, HR variability analysis (HRV2) during home-cage
conditioned fear; and ––%––, HR variability analysis
(HRV3) for the NK1 receptor antagonist fear-conditioning
treatment.
Heart rate variability in high anxiety mice 1349variability at low HR) to NAB levels. These ﬁndings
further demonstrate that changes observed in the
behavioural response are strongly associated with
changes in the cardiovascular system and thereby
alteration to the sympathovagal balance may account
for the pathological high anxiety of HAB mice. ROC
curve analysis validated RMSSD, as a measure of HR
variability, with high speciﬁcity and sensitivity in
distinguishing between normal vs. high trait anxiety.
Finally, the altered autonomic function of HR dy-
namics that was observed in HAB further validated
the mouse model, as it resembles the altered auto-
nomic regulation observed in patients suﬀering
from anxiety disorders (Cohen & Benjamin, 2006;
Friedman, 2007).
Basal autonomic regulation between HAB and
NAB mice
In the present study, HAB and NAB mice exhibited
similar circadian locomotor activity recorded by the
radio-transmitter supporting a previous study using a
diﬀerent technique (Kromer et al. 2005). Comparable
locomotor activity levels were observed in another
study in C57BL/6J mice using the same device
(Van Bogaert et al. 2006). Unaltered locomotor activity
observed in diﬀerent mouse lines demonstrates
that the ECG transmitter does not appear to aﬀect the
behavioural performance of mice after appropriate
recovery period (Stiedl et al. 2004).
Resting HR and HR variability did not diﬀer be-
tween HAB and NAB mice. These ﬁndings parallel
those of a study which reported that a rat model
selectively bred for high ultrasonic vocalization (USV),
exhibiting enhanced anxiety and depression-related
behaviour, displayed similar HR and HR variability
to low USV-emitting rats under resting conditions
but not under emotionally challenging conditions
(Brunelli & Hofer, 2007). Finally, a number of studies
in patients suﬀering from anxiety disorders failed to
ﬁnd diﬀerences in autonomic regulation during rest-
ing conditions (for review see Friedman, 2007). Thus,
in HAB and NAB mice the breeding strategy based on
a selection criterion of behavioural diﬀerence (i.e. open
arm time on the elevated plus maze), did not signiﬁ-
cantly aﬀect basal homeostatic mechanisms involved
in locomotor activity and HR regulation.
Autonomic and behavioural responses during
novelty exposure
There is evidence that changes in autonomic regu-
lation might be detected, particularly when the system
is challenged (for review see Berntson et al. 1998).
Exposure of rodents to a novel environment produces
autonomic adjustments (e.g. tachycardia) as a result of
unpredictability and unfamiliarity as well as physical
activity during exploration. Therefore, following a
baseline recording period in the home cage, behav-
ioural and autonomic responses of HAB and NAB
mice were determined to novelty exposure to a new
cage. Novelty exposure produced an increase in loco-
motor activity and was associated with increased HR
and decreased HR variability in both lines. However,
no diﬀerences between lines were found. High tachy-
cardic responses recorded in both HAB and NAB mice
reached similar levels to those reported in C57BL/6N
mice (Tovote et al. 2004) indicating that the general
dynamical range of cardiovascular regulation was not
altered in both lines. Hence, a challenge of increased
aversiveness such as auditory fear conditioning
was employed to test whether a perturbed autonomic
system might be present in the case of learned fear.
Fear and autonomic response during visual fear
conditioning
AsoutlinedintheIntroduction,mostfear-conditioning
protocols use footshock to elicit freezing behaviour.
Alternatively, an air stream used as tactile US in
aversive conditioning protocols (Landers & Sullivan,
1999) which has been shown to activate fear-related
brain areas (Salchner et al. 2006), might be considered
as less pain-related compared to footshock yet gener-
ating similar behavioural responses (e.g. similar USV
levels) (Knapp & Pohorecky, 1995). Hence, we evalu-
ated cardiovascular and fear responses provoked by
this non-painful yet aversive US paired with light as
CS. The behavioural fear response after ﬁve CS/US
pairings indicated similar levels of fear (y40% freez-
ing) in both lines. Locomotor activity was also similar
in both lines. However, the behavioural response was
associated with higher HR and reduced HR variability
in HAB mice compared to NAB mice.
Although it was possible to quantify HR variability,
movement-related artifacts confounded the ECG re-
cording during air-stream stimulation and required
precise manual editing for quantiﬁcation of HR varia-
bility. RMSSD is highly sensitive to artifacts and ecto-
pics produced to the ECG signal if unrecognized.
Nevertheless, this kind of analysis was necessary to
determine the cardiovascular responses concomitantly
with the behavioural responses.
Despite similar fear levels during conditioning
in both mouse lines, HAB mice showed higher fear
response and lower locomotor activity than NAB mice
during the retention test. The behavioural response
1350 S. Gaburro et al.was associated with higher HR and reduced HR
variability responses indicating that physical activity
was not the main determinant of the tachycardia.
Comparable cardiovascular responses have been ob-
served in other C57BL/6 substrains tested in auditory
fear conditioning (Stiedl et al. 1999). Since mice are
highly sensitive to any interference by an exper-
imenter (Stiedl et al. 2004), it cannot be excluded that
the HR and HR variability responses recorded during
our experiments were in part aﬀected by the human
interaction with the mice. The ﬁndings of reduced HR
variability after handling or novelty exposure are in
line with studies employing animal models of in-
creased anxiety upon phasic challenges (e.g. involving
chronic mild stress, or social isolation, or gene knock-
out) (Cohen et al. 2007; Costoli et al. 2004; Grippo et al.
2007; Groenink et al. 2003; Spani et al. 2003).
To isolate the CS-induced cardiovascular response
from unspeciﬁc stressors, we performed a retention
test of conditioned fear in the home cage.
Reduced HR variability in auditory fear retention
in the home cage
Retention tests of cued auditory conditioned fear can
be performed in the home cage thereby exploiting
autonomic readouts undisturbed from any unspeciﬁc
interference (for review see Stiedl et al. 2009).
Therefore, we used this successful approach in our
experiments. During CS presentation, both HAB and
NAB mice showed a clearly reduced locomotor
activity indicative, as shown by previous correlation
analysis, of enhanced fear. The activity suppression
was more pronounced in HAB mice than in NAB mice.
During the fear response, lower HR variability was
observed in HAB than in NAB mice. In contrast, HR
did not diﬀer between the lines indicating that the
diﬀerence in HR responses observed in the air-stream
fear-conditioning experiment was indeed the outcome
of emotional (CS-induced) plus physical (exper-
imenter handling) challenge.
Few studies have attempted to address the impact
of emotional challenge on the cardiovascular response
in inbred mouse strains using a familiar environment
(reviewed in Stiedl et al. 2009). The authors of that
series of studies conclude that environmental chal-
lenge, such as novelty exposure, increases physical
activity (as shown also in the present study) and thus
may easily elevate baseline HR to the level of aversive
challenge such as fear retention test. Thereby, future
studies should try to determine whether autonomic
eﬀects are attributable to anxiety, or simply to in-
creased locomotor activity.
In light of the ﬁndings presented here, it appears
that reduced HR variability, but not HR, is the only
reliable marker of enhanced fear/anxiety response in
our mouse model. Thus, modulation of the autonomic
response in HAB mice was studied in response to
eﬀective anxiolytic drug treatment.
Eﬀects of anxiolytic drug treatment on HR
variability
NK1 receptor antagonists have been shown to elicit
anxiolytic eﬀects in animals and humans (see
Introduction). Previous experiments using the light/
dark test demonstrated reduction of anxiety-like be-
haviour in HAB mice by chronic treatment with the
NK1 receptor antagonist L-822429 (S. B. Sartori et al.
unpublished observations). We have now revealed
that chronic treatment with this NK1 receptor antag-
onist greatly attenuated the freezing response and in-
creased the locomotor activity in the fear retention test,
indicating a profound fear-reducing eﬀect in HAB
mice. Interestingly, fear acquisition was not aﬀected,
as freezing responses were similar in control and
L-822429-treated mice following ﬁve sound/footshock
pairings. Additionally, pre-CS freezing and activity
levels were similar between the lines excluding seda-
tive eﬀects often described with BDZ treatment (see
Introduction). The fear-reducing eﬀect is consistent
with that observed using other NK1 receptor antag-
onists in unselected rodents (Rupniak et al. 2003; van
der Hart et al. 2005).
NK1 receptor antagonist treatment increased HR
variability during CS presentation to the level of NAB
mice, while basal and CS-induced HR responses re-
mained unaﬀected, despite somewhat reduced steep-
ness of the slope of the HR/HR variability function.
Interestingly, acute intracerebroventricular adminis-
tration of the NK1 receptor antagonists was shown to
reduce HR (Culman et al. 1997, 2010).
For a better understanding of modiﬁcation to the
sympathovagal balance mediated by the drug treat-
ment the HR/HR variability correlation analysis was
conducted incorporating all experimental data. This
correlation analysis was previously used for a quali-
tative description of eﬀects of pharmacological inter-
vention (Tovote et al. 2004) indicating a reduced
steepness of slope by intracerebroventricular injection
of an NPY1 receptor agonist that is attributed to
blunted sympathetic activity. The steepness of the
slope of the HR/HR variability correlation was much
lower in both HAB and NAB mice than previously
reported in C57BL/6N mice (Tovote et al. 2004). This
result indicates an altered sympathovagal antagonism
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ness of slopes is under genetic control as previously
shown in humans (Kupper et al. 2004) but opposed to
recent claims on HR variability of diﬀerent strains of
mice (Howden et al. 2008). Furthermore, the NK1 an-
tagonist L-822429 reduced the steepness of the RR/
RMMSD relationship, almost to the level of NAB mice,
i.e. resulted in a more regular HR dynamics. In line
with the present ﬁndings, successful anxiolytic/anti-
depressant treatment is associated with increased HR
variability upon challenge but not under resting con-
dition (Cohen et al. 2000; Fraguas et al. 2007). BDZs,
such has diazepam, have been reported to increase HR
variability (Ikeda et al. 1994) but results are inconsist-
ent (Agelink et al. 2002). In contrast, reduced basal HR
variability has also been reported after long-term
antidepressant treatment in humans (Licht et al. 2010).
Conceptually, an increase in HR variability is thought
to be physiologically favourable and successful
anxiolytic treatment should restore the potentially
altered cardiovascular dynamics towards an enhanced
parasympathetic tone combined with attenuated
sympathetic activity by decreasing altered limbic
(amygdala) activity previously observed in our mouse
model (Muigg et al. 2009), resulting in normalization of
dysfunctional brain–heart interaction.
RMSSD – from HR variability to biomarker?
The experiments suggest that RMSSD may serve as
indicator to distinguish normal from pathological trait
anxiety. Speciﬁcally, optimal cut-oﬀ calculated indi-
cate a range or RMSSD values (between 0.587 and
0.723 ms) above which HR variability is considered
‘non-pathological’ and may be used as reference
values for future testing of new anxiolytic drugs in
HAB mice.
A recent study has provided evidence of the use-
fulness of integrating HR variability assessment into
the context of a broader analysis spectrum that takes
into consideration the interaction of dysfunctional
physiological systems of the whole organism (Cerutti
et al. 2009). This holistic approach considers the dis-
order-related dysfunction occurring concomitantly
at several organs (i.e. central and autonomic nervous
system, respiratory system, immune system, endo-
crine–metabolic systems). The approach combined
with multivariate statistical analysis and nonlinear
associations between diﬀerent physiological signals
could provide fundamental novel information, which
might not only contribute to improved risk stratiﬁ-
cation in humans but also to a better understanding of
the symptom progression with earlier diagnosis.
Therefore, this integral approach to monitor diﬀerent
physiological domains needs to be applied in the dif-
ferent rodent models of psychiatric disorders to more
closely mirror the human pathology and improve its
translational value.
Conclusion
Taken together the present study shows that elevated
fear responses in HAB mice are extended to altered
autonomic function indicating the importance of an
integral characterization of anxiety-like behaviour in-
volving physiological responses. The observed blunt-
ing of the hyperemotional responses in HAB mice by
the NK1 receptor antagonist concomitant with nor-
malization of the reduced HR variability may further
indicate that anxiolytic eﬀects of drug treatments in
hyperanxiety might be studied by regularization of
HR dynamics.
Note
Supplementary material accompanies this paper on
the Journal’s website (http://journals.cambridge.org/
pnp).
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